Licht C, Heinen S, Józsi M, Löschmann I, Saunders R E, Perkins S J, Waldherr R, Skerka C, Kirschfink M, Hoppe B, Zipfel P F
Children's Hospital of the University of Cologne, Pediatric Nephrology, Cologne, Germany.
Kidney Int. 2006 Jul;70(1):42-50. doi: 10.1038/sj.ki.5000269. Epub 2006 Apr 12.
We report a novel pathomechanism for membranoproliferative glomerulonephritis type II (MPGN II) caused by a mutant Factor H protein expressed in the plasma. Genetic analyses of two patients revealed deletion of a single Lys residue (K224) located within the complement regulatory region in domain 4 of Factor H. This deletion resulted in defective complement control: mutant protein purified from the plasma of patients showed severely reduced cofactor and decay-accelerating activity, as well as reduced binding to the central complement component C3b. However, cell-binding activity of the mutant protein was normal and comparable to wild-type Factor H. The patients are daughters of consanguineous parents. As both patients but also their healthy mother were positive for C3 nephritic factor, the mutant Factor H protein is considered relevant for unrestricted activation of the disease-causing activation of the alternative complement pathway. Replacement of functional Factor H by fresh frozen plasma (10-15 ml/kg/14 days) was well tolerated, prevented so far disease progression in both patients, and is in the long run expected to preserve kidney function.
我们报告了一种由血浆中表达的突变型H因子蛋白引起的II型膜增生性肾小球肾炎(MPGN II)的新发病机制。对两名患者的基因分析显示,H因子第4结构域补体调节区域内的单个赖氨酸残基(K224)缺失。这种缺失导致补体控制缺陷:从患者血浆中纯化的突变蛋白显示辅因子和衰变加速活性严重降低,以及与补体中心成分C3b的结合减少。然而,突变蛋白的细胞结合活性正常,与野生型H因子相当。患者是近亲结婚父母的女儿。由于两名患者及其健康母亲的C3肾炎因子均呈阳性,因此突变型H因子蛋白被认为与替代补体途径的致病激活不受限制有关。用新鲜冷冻血浆(10 - 15 ml/kg/14天)替代功能性H因子耐受性良好,迄今为止防止了两名患者的疾病进展,从长远来看有望保留肾功能。